Fda Revokes Avastin For Breast Cancer Use

 
Published on Nov. 18, 2011

The FDA has announced that the blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects. (Nov. 18)